Mirum Pharmaceuticals, Inc.
MIRM
$102.19
-$9.21-8.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13,689.79% | -297.25% | 149.56% | 60.07% | 38.31% |
| Total Depreciation and Amortization | 13.17% | 0.20% | 0.10% | 0.07% | -0.07% |
| Total Amortization of Deferred Charges | 4.13% | -1.58% | 3.75% | -1.39% | 4.09% |
| Total Other Non-Cash Items | 2,241.89% | 6.44% | 0.85% | 2.54% | 25.81% |
| Change in Net Operating Assets | 829.77% | -215.33% | 285.25% | 41.97% | -571.64% |
| Cash from Operations | -3,870.61% | -84.71% | 229.58% | 713.97% | 61.31% |
| Capital Expenditure | -10.67% | -220.86% | -48.41% | -207.32% | -105.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -779.02% | 178.73% | 68.48% | 59.78% | -2,534.64% |
| Cash from Investing | -1,250.00% | 145.17% | 66.25% | 59.10% | -2,617.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,996.78% | -44.09% | 85.27% | 36.63% | 19.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,901.21% | -44.09% | 85.27% | 36.63% | 19.08% |
| Foreign Exchange rate Adjustments | -211.76% | -216.91% | -84.32% | 111.00% | 176.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.79% | -70.94% | 229.56% | 253.12% | -2,192.06% |